Genix Pharmaceuticals Corporation

TSXV:GENX Stock Report

Market Cap: CA$2.4m

Genix Pharmaceuticals Past Earnings Performance

Past criteria checks 0/6

Genix Pharmaceuticals's earnings have been declining at an average annual rate of -48.8%, while the Personal Products industry saw earnings growing at 11.1% annually. Revenues have been declining at an average rate of 89% per year.

Key information

-48.8%

Earnings growth rate

-46.1%

EPS growth rate

Personal Products Industry Growth35.8%
Revenue growth rate-89.0%
Return on equityn/a
Net Margin-39,014.4%
Last Earnings Update31 Jan 2024

Recent past performance updates

Recent updates

Did Genix Pharmaceuticals Corporation (CVE:GENX) Insiders Buy Up More Shares?

Jan 17
Did Genix Pharmaceuticals Corporation (CVE:GENX) Insiders Buy Up More Shares?

Revenue & Expenses Breakdown
Beta

How Genix Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:GENX Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jan 240-400
31 Oct 230-400
31 Jul 230-100
30 Apr 230-100
31 Jan 230-100
31 Oct 220-100
31 Jul 220-110
30 Apr 220-110
31 Jan 220-210
31 Oct 210-210
31 Jul 210-210
30 Apr 210-110
31 Jan 210-110
31 Oct 200-100
31 Jul 200000
30 Apr 200000
31 Jan 200000
31 Oct 190000
31 Jul 190000
30 Apr 190000
31 Jan 190000
31 Oct 180000
31 Jul 180000
30 Apr 180000
31 Jan 180000
31 Oct 170000
31 Jul 171000
30 Apr 171010
31 Jan 171010
31 Oct 161010
31 Jul 161010
30 Apr 161010
31 Jan 161010
31 Oct 151-110
31 Jul 151000
30 Apr 151000
31 Jan 150000
31 Oct 140000
31 Jul 141000
30 Apr 140000
31 Jan 141000
31 Oct 131000
31 Jul 130000

Quality Earnings: GENX is currently unprofitable.

Growing Profit Margin: GENX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: GENX is unprofitable, and losses have increased over the past 5 years at a rate of 48.8% per year.

Accelerating Growth: Unable to compare GENX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GENX is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (-5.2%).


Return on Equity

High ROE: GENX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.